BIRCH team
Washington Post Kristie Ebi climate change 2020 Presidential Election global health News
June 28, 2019 | Health News

A Climate-focused Presidential Debate? Here’s What Moderators Should Ask

Jay Inslee, the governor of Washington state, has said climate change is the “driving motivation” for his presidential campaign; some of his opponents agree, particularly after an April CNN/SSRS poll found that 82 percent of Democrats and Democratic-leaning voters described the issue as “very important.” One of these candidates will face off in the general election against a president who ran on the assurance that “I believe in clean air. Immaculate air.

BIRCH team
BMJ global health Research Integrity Independence
June 28, 2019 | Health News

BMJ Editorial: Protect the Independence of Global Health Research

Seven University of Washington faculty members recently joined more than 200 researchers from 40 different countries in a call to action to protect the independence and integrity of global health research.  The editorial, published in the most recent issue of BMJ Global Health, highlights the pervasiveness of donor and NGO influence on program evaluation findings and dissemination.

BIRCH team
HIV Wasserheit
June 25, 2019 | Health News

They Thought This HIV Strategy Couldn't Work. But It Did

In high-income countries like the U.S., the standard of care for people infected by HIV is to provide antiretroviral pills when the virus is found, even when there are no symptoms of AIDS. The strategy staves off the disease and has a second – big – benefit. It's been shown to prevent the spread of HIV in sexual encounters. It's called "treatment as prevention" (TasP in medical jargon), or "test and treat."

But in low-income countries, "test and treat" is not the typical approach to prevention. There's been no research to support it.

BIRCH team
February 15, 2019 | Health News

Mind the Gap: The Burden of HIV Among Racial and Ethnic Minority Groups and Their Participation in Preventive HIV Vaccine Clinical Trials

An analysis conducted by the HIV Vaccine Trials Network (HVTN) observed an overall increase in the proportion of racial and ethnic minorities enrolled in Phase 1 and Phase 2A preventive HIV vaccine clinical trials in the United States between 2002 and 2016 compared to 1988 to 2002. The findings were published on December 5, 2018 in Public Health Reports.

Pages